BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Aug 15, 2011
 |  BC Week In Review  |  Clinical News  |  Clinical Status

Northera droxidopa: Completed Phase II enrollment

Chelsea completed enrollment of 120 patients in the double-blind, U.K. Phase II FMS201 trial. The 12-arm study is evaluating 200, 400 or 600 mg of oral droxidopa given 3 times daily; 25 or 50 mg carbidopa given 3 times daily; 200/25 mg,...

Read the full 186 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >